Decay of passively acquired maternal antibodies against measles, mumps, and rubella viruses

Clinical and Diagnostic Laboratory Immunology

Volumn 6, Issue 6, 1999, Pages 868-871

  Nicoara, Corina ^b   Zäch, Kristina ^b   Trachsel, Daniel ^b   Germann, Daniel ^b   Matter, Lukas ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES ANTIBODY; MEASLES MUMPS RUBELLA VACCINE; MUMPS ANTIBODY; RUBELLA ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

AGE; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; MALE; MEASLES VIRUS; MUMPS VIRUS; PASSIVE IMMUNIZATION; PRESCHOOL CHILD; PRIORITY JOURNAL; RUBELLA VIRUS; SEROPREVALENCE; SEX DIFFERENCE; VACCINATION;

EID: 0344672305     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.6.6.868-871.1999     Document Type: Article

References (38)

1. Altintas, D. U., N. Evliyaoglu, B. Kilinc, D. I. Sen'an, and S. Guneser. 1996. The modification in measles vaccination age as a consequence of the earlier decline of transplacentally transferred antimeasles antibodies in Turkish infants. Eur. J. Epidemiol. 12:647-648.
2. Anderson, R. M., and R. M. May. 1983. Vaccination against rubella and measles: quantitative investigations of different policies. J. Hyg. Camb. 90: 259-325.
3. Babad, H. R., D. J. Nokes, N. J. Gay, E. Miller, P. Morgan-Capner, and R. M. Anderson. 1995. Predicting the impact of measles vaccination in England and Wales: model validation and analysis of policy options. Epidemiol. Infect. 114:319-344.
4. Brugha, R., M. Ramsay, T. Forsey, and D. Brown. 1996. A study of maternally derived measles antibody in infants born to naturally infected and vaccinated women. Epidemiol. Infect. 117:519-524.
5. Centers for Disease Control and Prevention. 1993. Measles - United States, 1992. Morbid. Mortal. Weekly Rep. 42:378-381.
6. Centers for Disease Control and Prevention. 1997. Measles outbreak - southwestern Utah, 1996. Morbid. Mortal. Weekly Rep. 46:766-769.
7. Clarke, M., J. A. Dudgeon, A. Ferris, G. Colinet, H. Tate, and F. T. Perkins. 1975. The British standard for anti-rubella serum. J. Biol. Stand. 3:151-161.
8. Dabis, F., R. J. Waldman, G. F. Mann, D. Commenges, G. Madzou, and T. S. Jones. 1989. Loss of maternal measles antibody during infancy in an African city. Int. J. Epidemiol. 18:264-268.
9. Dagan, R., P. E. Slater, P. Duvdevani, N. Golubev, and E. Mendelson. 1995. Decay of maternally derived measles antibody in a highly vaccinated population in southern Israel. Pediatr. Infect. Dis. J. 14:965-969.
10. De Serres, G., N. Boulianne, F. Meyer, and B. J. Ward. 1995. Measles vaccine efficacy during an outbreak in a highly vaccinated population: incremental increase in protection with age at vaccination up to 18 months. Epidemiol. Infect. 115:315-323.
11. De Serres, G., N. Boulianne, S. Ratnam, and A. Corriveau. 1996. Effectiveness of vaccination at 6 to 11 months of age during an outbreak of measles. Pediatrics 97:232-235.
12. Diem, K., and C. Lentner. 1968. Documenta Geigy. Wissenschaftliche Tabellen. J. R. Geigy SA, Basel, Switzerland.
13. Fakultäre Instanz für Allgemeinmedizin and Bundesamt für Gesundheit. 1999. Sentinella 1997. Annual report of the Swiss Sentinel Surveillance Network. Swiss Federal Office of Public Health, Bern, Switzerland.
14. Gerike, E., G. Rasch, A. Tischer, and S. Santibanez. 1997. Measles in Germany. Eurosurveillance 2:88-90.
15. Germann, D., A. Ströhle, K. Eggenberger, C. A. Steiner, and L. Matter. 1996. An outbreak of mumps in a population partially vaccinated with the Rubini strain. Scand. J. Infect. Dis. 28:235-238.
16. Halsey, N. A., R. Boulos, F. Mode, J. Andre, L. Bowman, R. G. Yaeger, S. Toureau, J. Rohde, and C. Boulos. 1985. Response to measles vaccine in Haitian infants 6 to 12 months old. Influence of materhal antibodies, malnutrition, and concurrent illnesses. N. Engl. J. Med. 313:544-549.
17. Johnson, C. E., D. R. Nalin, L. W. Chui, J. Whitwell, R. G. Marusyk, and M. L. Kumar. 1994. Measles vaccine immunogenicity in 6- versus 15-month-old infants born to mothers in the measles vaccine era. Pediatrics 93:939-943.
18. Kacica, M. A., R. A. Venezia, J. Miller, P. A. Hughes, and M. L. Lepow. 1995. Measles antibodies in women and infants in the vaccine era. J. Med. Virol. 45:227-229.
19. Kiepiela, P., H. M. Coovadia, W. E. Loening, P. Coward, and S. S. Abdool Karim. 1991. Loss of maternal measles antibody in black South African infants in the first year of life - implications for age of vaccination. S. Afr. Med. J. 79:145-148.
20. King, G., L. Markowitz, S. Burns, J. Heath, J. Nordin, and W. Bellini. 1994. A comparison of seroconversion rates to measles vaccine of children vaccinated at 9, 12, or 15 months of age, abstr. H-108. In Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
21. Lennon, J. L., and F. L. Black. 1986. Maternally derived measles immunity in era of vaccine-protected mothers. J. Pediatr. 108:671-676.
22. Lévy Bruhl, D., R. Pebody, I. Veldhuijzen, M. Valenciano, and K. Osborne. 1999. ESEN: a comparison of vaccination programmes. Part three: measles, mumps, and rubella. Eurosurveillance 3:115-119.
23. Maldonado, Y. A., E. C. Lawrence, R. De Hovitz, H. Hartzell, and P. Albrecht. 1995. Early loss of passive measles antibody in infants of mothers with vaccine-induced immunity. Pediatrics 96:447-450.
24. Matter, H. C., J. Cloëtta, and H. Zimmermann. 1995. Measles, mumps, and rubella: monitoring in Switzerland through a sentinel network, 1986-94. J. Epidemiol. Community Health 49:4-8.
25. Matter, L., F. Bally, D. Germann, and K. Schopfer. 1995. The incidence of rubella virus infections in Switzerland after the introduction of the MMR mass vaccination programme. Eur. J. Epidemiol. 11:305-310.
26. Matter, L., D. Germann, F. Bally, and K. Schopfer. 1997. Age-stratified seroprevalence of measles, mumps, and rubella (MMR) virus infections in Switzerland after the introduction of MMR mass vaccination. Eur. J. Epidemiol. 13:61-66.
27. Matter, L., K. Kogelschatz, and D. Germann. 1997. Serum levels of rubella virus antibodies indicating immunity: response to vaccination of subjects with low or undetectable antibody concentrations. J. Infect. Dis. 175:749-755.
28. McLean, A. R. 1992. Mathematical modelling of the immunisation of populations. Rev. Med. Virol. 2:141-152.
29. Nokes, D. J., and R. M. Anderson. 1988. The use of mathematical models in the epidemiological study of infectious diseases and the design of mass immunization programmes. Epidemiol. Infect. 101:1-20.
30. Pabst, H. F., D. W. Spady, R. G. Marusyk, M. M. Carson, L. W. Chui, M. R. Joffres, and K. M. Grimsrud. 1992. Reduced measles immunity in infants in a well-vaccinated population. Pediatr. Infect. Dis. J. 11:525-529.
31. Peltola, H., O. P. Heinonen, M. Valle, M. Paunio, M. Virtanen, V. Karanko, and K. Cantell. 1994. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program. N. Engl. J. Med. 331:1397-1402.
32. Robert Koch Institut. 1999. Annual report on important infectious diseases in Germany. Part 5. Vaccine preventable diseases: diphtheria, tetanus, poliomyelitis, pertussis, measles, mumps, and rubella. Epidemiologisch. Bull. 19:139-143.
33. Rota, J. S., P. A. Rota, S. B. Redd, S. C. Redd, S. Pattamadilok, and W. J. Bellini. 1998. Genetic analysis of measles viruses isolated in the United States, 1995-1996. J. Infect. Dis. 177:204-208.
34. Sato, H., P. Albrecht, D. W. Reynolds, S. Stagno, and F. A. Ennis. 1979. Transfer of measles, mumps, and rubella antibodies from mother to infant. Its effect on measles, mumps, and rubella immunization. Am. J. Dis. Child. 133:1240-1243.
35. Shasby, D. M., T. C. Shope, H. Downs, K. L. Herrmann, and J. Polkowski. 1977. Epidemic measles in a highly vaccinated population. N. Engl. J. Med. 296:585-589.
36. Vitek, C. R., S. C. Redd, S. B. Redd, and S. C. Hadler. 1997. Trends in importation of measles to the United States, 1986-1994. JAMA 277:1952-1956.
37. Wilkins, J., and P. F. Wehrle. 1979. Additional evidence against measles vaccine administration to infants less than 12 months of age: altered immune response following active/passive immunization. J. Pediatr. 94:865-869.
38. Zäch, K., C. Nicoara, D. Germann, and L. Matter. 1998. Altersabhängige Seroprävalenz von Masern-, Mumps- und Rötelnantikörpern im Jahr 1996. Schweiz. Med. Wochenschr. 128:649-657.